Chunping Yang

Chunping Yang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
XZXu Zhang
Xu Zhang
CYChunhong Yu
Chunhong Yu
PWPeng Wang
Peng Wang
CYChunping Yang
Chunping Yang
The increasing prevalence of microplastics (MPs) in the environment has raised urgent concerns regarding their implications for human health. This comprehensive review integrates recent findings on the sources, classification, and pathways of MPs into the human body, highlighting their potential cellular toxicity and systemic health risks. We discuss the mechanisms by which MPs may induce inflammatory responses, oxidative stress, and cellular damage, thereby contributing to various diseases. Notably, we examine the synergistic effects of MPs in conjunction with other environmental pollutants, which may amplify their adverse health outcomes. This synthesis of current research underscores the critical need for multidisciplinary approaches to investigate the multifaceted interactions between MPs and human health, ultimately guiding future studies and informing public health strategies to mitigate exposure and associated risks.

1 January 2026 in International Journal of Biological Sciences
Verified
Journal Article
Open access
PDF file
XZXu Zhang
Xu Zhang
ZZZhiqiang Zhang
Zhiqiang Zhang
QPQian Peng
Qian Peng
XHXinyu Huang
Xinyu Huang
MLMengyuan Liu
Mengyuan Liu
CYChunping Yang
Chunping Yang
Allergic Rhinitis (AR) is a highly prevalent type 2 inflammatory disease driven by a complex immunogenetic background. This review aims to systematically delineate the immunogenetic landscape of AR, elucidating the complete knowledge chain from macroscopic cellular interactions and microscopic molecular regulation to precision targeted therapies. The article first dissects the two core immune axes driving the pathological process of AR: one is the classic adaptive immune pathway, centered on Th2 cells, which mediates IgE production, eosinophil infiltration, and mucus hypersecretion through the secretion of cytokines such as IL-4, IL-5, and IL-13; the other is the innate immune initiation pathway, in which nasal epithelial cells act as "sentinels" by releasing "alarmins" like TSLP and IL-33, leading to the rapid activation of type 2 innate lymphoid cells (ILC2s). The review then delves into the sophisticated signaling networks that regulate these immune responses, with a particular focus on the classic IL-4/STAT6/GATA3 signaling axis and its negative regulatory mechanisms. Building on this, the article further elaborates on the genetic susceptibility architecture of AR, highlighting key risk loci identified by genome-wide association studies (GWAS), such as variants in antigen presentation genes (HLA), epithelial barrier genes (FLG), and genes related to cytokine signaling pathways. To connect genetics with the environment, this review systematically summarizes epigenetic regulatory mechanisms, including DNA methylation, histone modifications, and microRNAs (miRNAs), and discusses the long-range immunomodulatory effects of nasal and gut microbiota dysbiosis on AR via the "gut-nasal axis". Finally, from a translational medicine perspective, the article demonstrates how a profound understanding of these pathophysiological mechanisms has successfully spurred the development of highly effective targeted biologics, such as omalizumab (targeting IgE), dupilumab (targeting the IL-4Rα receptor, thus blocking IL-4/IL-13 signaling), and tezepelumab (targeting TSLP). This review integrates the latest multidimensional research advances in immunology, genetics, epigenetics, and microbiome studies of AR, providing a comprehensive theoretical framework for understanding its complex pathogenesis and for the development of future personalized treatment strategies.

1 July 2021 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
XCXubo Chen
Xubo Chen
QZQi Zhang
Qi Zhang
CYChunping Yang
Chunping Yang
YLYuehui Liu
Yuehui Liu
LLLihua Li
Lihua Li
Background: In recent years, the incidence of sudden deafness has gradually increased, with a very limited understanding of its etiology and pathogenesis. Glucocorticoids are the first choice of the treatment, but some hormone-resistant patients are not sensitive to glucocorticoid therapy. The pathogenesis is not yet known. In this study, we aim to construct the HEI-OC1 cell line stably overexpressing Glucocorticoid Receptor Beta (GRβ), and identify its exact role in the cases of glucocorticoidresistant sudden deafness. Methods: We used the endotoxin lipopolysaccharide-stimulated cochlear hair cells (HEI-OC1) to investigate the relationship of inflammation factor IL-2, TNF alpha, and SRp30c with the high expression GRβ. We built a stable GRβ high expression HEI-OC1 cell line and clarified its effects on the therapeutic effect of dexamethasone. MTT assay, colony formation assay, CCK-8 assay, Western blot, and RT-qPCR were utilized for characterizations. Results: Dexamethasone reduced the LPS-induced inflammatory response from HEI-OC1 cells (p<0.05), detected by MTT assay. Dexamethasone could protect HEI-OC1 cells, but its protective effect was weakened due to the transfection of SRp30c over-expression plasmid (p<0.05). The transfection of SRp30c over-expression plasmid in HEI-OC1 cells could elevate the expressions of GRβ (p<0.05). Conclusion: : We clarified the mechanisms of high expression of GRβ in glucocorticoid-resistant sudden sensorineural hearing loss, and proved that the inhibition of SRp30c may act as a new treatment way of glucocorticoid-resistant sudden sensorineural hearing loss.

1 October 2025 in Environmental Research
Verified
Journal Article
Closed access
XZXu Zhang
Xu Zhang
MLMengyuan Liu
Mengyuan Liu
ZZZhiqiang Zhang
Zhiqiang Zhang
XHXinyu Huang
Xinyu Huang
DBDaoming Bai
Daoming Bai
CYChunping Yang
Chunping Yang

6 October 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
WWWei Wan
Wei Wan
YQYi Qiu
Yi Qiu
XHXinyi Huang
Xinyi Huang
YRYingxiang Ren
Yingxiang Ren
APAndi Peng
Andi Peng
CYChunping Yang
Chunping Yang
Background: Growing evidence has well documented the close association between the gut microbiome and allergic respiratory disease, which has been notably represented by allergic asthma. However, it is unclear whether this association is a causal link. Therefore, we investigated the potential causal associations between the gut microbiome and allergic asthma or other allergic diseases.Methods: In this study, we performed two-sample Mendelian randomization (MR) analyses by using the publicly available genome-wide association study (GWAS) summary data. Single-nucleotide polymorphisms (SNPs) that significantly correlated were selected as instrumental variables. The inverse variance weighted (IVW) method was used to examine the potential causal gut microbial genera for allergic asthma and other allergic diseases. The robustness of the primary findings of the MR analyses was ensured by using different sensitivity analyses.Results: Combining the findings from multiple analyses, the host genetic-driven increases in Butyricimonas at the genus level were positively correlated with the risk of allergic asthma. In addition, phylum Bacteroidetes and class Bacteroidia were also found to have negative associations with the risk of allergic asthma; genus Slackia was identified as having potential causal effects with allergic asthma. No clear evidence of pleiotropy and heterogeneity was observed in genus Butyricimonas. Butyricimonas was also found to have an association with allergic rhinitis, but not with other allergic diseases.Conclusion: Our findings indicate that there are new gut microbial genera that were causally associated with the risk of allergic asthma and other allergic diseases, and offer novel insights into the pathogenesis of allergic respiratory diseases.

25 August 2025 in Environmental Geochemistry and Health
Verified
Journal Article
Closed access
PDF file
MLMengyuan Liu
Mengyuan Liu
XZXu Zhang
Xu Zhang
XHXinyu Huang
Xinyu Huang
CYChunping Yang
Chunping Yang